Home|Journals|Articles by Year|Audio Abstracts
 

Review Article

IJMDC. 2019; 3(1): 117-119


Proton-pump inhibitors use and risk of acute kidney injury

Majed Hassan Alghamdi, Yousef Ali Abdali, Jamilah Saleh Alyami, Hala Ahmed Aljohani, Majid Jobran Lughbi, Amnah Essa Abu Lahsah, Waleed Ali Fehran Alshehri, Nawal Ahmed Alshammari, Ali Omar Alshargi.




Abstract

Acute interstitial nephritis associated with proton pump inhibitor is an immunologically mediated renal injury that is estimated to be one-quarter of the cases of acute kidney injury. Review of recent updates of the relationship between proton pump inhibitor use and development of interstitial nephritis in the period from 2008 to 2018 were included. Scientific websites were used to search for articles related to the subjects such as PubMed and Google scholar using several keywords including proton pump inhibitors, acute interstitial nephritis, adverse effects, and morbidity. 30 articles were obtained, 23 of them were included whereas the rest were excluded as their focus was different. Proton pump inhibitor-related interstitial nephritis is rare, quirky and challenging to suspect. It requires a high level of clinical prediction and knowledge. However, PPI use could be a risk factor for acute interstitial nephritis and should be administered carefully.

Key words: proton pump inhibitors, acute interstitial nephritis, adverse effects, and morbidity






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.